What is Sorrento Therape?
, a clinical and commercial stage biopharmaceutical company, provides therapeutic solutions in the United States and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical and commercial stage biopharmaceutical company, provides therapeutic solutions in the United States and internationally. It offers chimeric antigen receptor T-cell therapy, dimeric antigen receptor T-cell therapy, and antibody-drug conjugates, as well as Seprehvec, SOFUSA, RTX, and SEMDEXA. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 1.82M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.